Atorvastatin (Lipitor): how much it lowers LDL, side effects and the blood tests that go with it

The dose decides how far your LDL falls; your starting LDL and heart risk decide what that fall is worth. What each dose does, the side-effect rates from blinded trials, the interactions with hard dose limits, and the blood tests that show whether atorvastatin is working for you.

Reviewed by LifeFrom’s medical AIPublished November 20, 2026 · 10 min read
Ask AI about this pageChatGPTClaudePerplexity
The distinctions
  1. 01
    The dose sets the percentage; your starting point sets the benefit

    Atorvastatin lowers LDL by roughly the same percentage in everyone on a given dose (about 37 to 51 percent from 10 to 80 mg), but the protection depends on how many mg/dL that removes and how high your risk was, so the same tablet can be worth several times more to one person than another.

  2. 02
    Most muscle aches on atorvastatin also happen on placebo

    In 19 blinded trials, 27.1 percent on a statin and 26.6 percent on placebo reported muscle symptoms; only about 1 in 15 first-year reports was caused by the statin, which is why prescribers check CK and try the tablet again after a short break before giving up on it.

  3. 03
    Liver tests are a starting check; repeat them only for symptoms

    The US label suggests a liver test before starting atorvastatin and then only if symptoms suggest a problem; the lipid panel within 12 weeks is the test that tracks treatment.

The dose of atorvastatin sets how far your LDL cholesterol falls as a percentage, from about 37 percent at 10 mg a day to 51 percent at 80 mg in the STELLAR trial 2. Where you start decides what that percentage is worth. People who begin with a higher LDL and a higher heart risk lose more mg/dL and avoid more heart attacks and strokes on the same tablet 4.

What is atorvastatin used for, and how does it work?

Atorvastatin is prescribed to lower LDL cholesterol and cut the chance of a heart attack or stroke. The 2026 ACC/AHA dyslipidemia guideline, which replaced the 2018 one in March 2026, recommends treatment for people with heart or artery disease, for adults 40 to 75 with diabetes, stage 3 or 4 chronic kidney disease or HIV, and for adults whose 10-year risk is 5 percent or more 7. That risk is your clinician's estimate, from age, blood pressure, cholesterol, smoking and diabetes, of a heart attack or stroke in the next 10 years; if yours is borderline, a coronary calcium score can help decide 7. High cholesterol covers the wider picture.

Atorvastatin, sold as Lipitor since 1996 1 and as a low-cost generic since late 2011, blocks HMG-CoA reductase, the enzyme the liver uses to make cholesterol. Liver cells respond by pulling more LDL particles out of the blood, so blood LDL falls. Most of the effect appears within 2 weeks and the full effect by about 4 1.

How much does atorvastatin lower LDL?

Atorvastatin lowers LDL cholesterol by about 37 percent at 10 mg a day, rising to about 51 percent at 80 mg, in STELLAR, a 6-week head-to-head statin trial 2. The ACC/AHA calls a 30 to 49 percent drop moderate intensity and 50 percent or more high intensity 3.

Daily doseAverage LDL drop at 6 weeksIntensity (ACC/AHA)Example: LDL starting at 160 mg/dL (4.1 mmol/L)
10 mg37%ModerateAbout 101 mg/dL (2.6 mmol/L)
20 mg43%ModerateAbout 91 mg/dL (2.4 mmol/L)
40 mg48%HighAbout 83 mg/dL (2.1 mmol/L)
80 mg51%HighAbout 78 mg/dL (2.0 mmol/L)

Each doubling of the dose adds only about 3 to 6 percentage points 2, and individual responses spread widely around these averages. Apolipoprotein B (ApoB, a count of the particles that carry LDL) falls by a smaller percentage than LDL on the same dose 1 2. Our ApoB vs LDL comparison notes that when the two disagree, "usually with high triglycerides, insulin resistance, type 2 diabetes or a low LDL on treatment", heart risk tracks ApoB more closely; what a high ApoB means covers the next step. Atorvastatin also lowers small dense LDL and cuts triglycerides by roughly 20 to 30 percent 2 (cholesterol vs triglycerides explains the difference), but it does not lower lipoprotein(a).

An LDL result after starting atorvastatin 40 mg
mg/dLHalf of 160 (a 50% drop)StartWeek 1Week 2Week 3Week 4Week 8Week 12Full effect by about week 4
Illustrative: one person starting at 160 mg/dL on 40 mg a day, shaped by the label's onset times 1 and the 48 percent average drop at 40 mg in STELLAR 2.

Does atorvastatin prevent heart attacks and strokes?

Atorvastatin cuts heart attacks and strokes in outcome trials in people with and without heart disease, including people with high blood pressure and average cholesterol, and in people who have already had a heart attack or stroke 1 8 9.

TrialWho took partComparisonResult
ASCOT-LLA10,305 people with high blood pressure and average or below-average cholesterol10 mg vs placebo36% fewer nonfatal heart attacks and coronary deaths; stopped early at a median 3.3 years 1
CARDS2,838 people with type 2 diabetes and no heart disease10 mg vs placebo37% fewer major cardiovascular events and 48% fewer strokes 1
TNT10,001 people with stable coronary heart disease80 mg vs 10 mgMajor cardiovascular events 8.7% vs 10.9% over a median 4.9 years; total deaths did not differ 1
PROVE IT-TIMI 224,162 people in hospital with a heart attack or unstable angina80 mg vs pravastatin 40 mgMedian LDL 62 vs 95 mg/dL; 16% fewer deaths and major cardiovascular events at 2 years 8
SPARCL4,731 people with a recent stroke or mini-stroke (TIA) and no heart disease80 mg vs placeboFatal or nonfatal stroke 11.2% vs 13.1% over a median 4.9 years, with a small rise in bleeding strokes 9

How to take atorvastatin

Take atorvastatin once a day, at whatever time is easiest to keep the same. Its effect on the liver enzyme lasts 20 to 30 hours, so morning and evening doses work equally well, and kidney disease needs no dose change 1. If you miss a dose, the label says to take it when you remember unless more than 12 hours have passed, and never to take two doses together 1.

How atorvastatin is taken, from the US label

With foodWith or without food; the dose works the same either way [[1]].
How oftenOnce a day, at a time that is easy to keep the same each day [[1]].
Space ~2h fromLarge amounts of grapefruit juice: no more than 1.2 liters a day [[1]]Clarithromycin, itraconazole and several HIV and hepatitis C medicines: the dose limit is 20 mg [[1]]Gemfibrozil and cyclosporine: avoid the combination [[1]]

Atorvastatin vs rosuvastatin, simvastatin and add-on drugs

Milligrams do not carry across statins. Rosuvastatin is stronger per milligram, so 20 mg of rosuvastatin already counts as high intensity, while atorvastatin needs 40 to 80 mg to get there 3. Simvastatin is weaker and shorter-acting, which is why it is the one usually taken in the evening. The statins guide compares the whole class.

When a statin alone does not reach the LDL goal, the guideline adds a non-statin: ezetimibe (a tablet that blocks cholesterol absorption in the gut), bempedoic acid, or an injectable PCSK9 inhibitor such as evolocumab 7. Add-ons lower what is left, so percentages multiply. A 50 percent statin drop plus a drug that removes 20 percent of the rest is 60 percent in total, not 70.

Atorvastatin side effects: what is common and what is rare

Blinded trials show that most muscle aches on a statin are not caused by it. Across 19 double-blind trials pooled by the Cholesterol Treatment Trialists, 27.1 percent of people on a statin and 26.6 percent on placebo reported muscle pain or weakness over about 4 years; the excess was about 11 reports per 1,000 people in the first year and none after that 5.

1 in 15muscle-symptom reports in the first year on a statin that the statin itself causedCholesterol Treatment Trialists, 19 blinded trials, Lancet 2022 5

Serious muscle breakdown (rhabdomyolysis) is rare: about 0.44 hospital admissions per 10,000 person-years on atorvastatin, pravastatin or simvastatin alone 11. The label lists what raises the risk: higher doses, age 65 or over, an untreated underactive thyroid, kidney disease and the interacting drugs in the table below 1.

Blood sugar rises a little on statins. In the 2024 Cholesterol Treatment Trialists analysis, high-intensity statins raised new diabetes diagnoses by 36 percent in relative terms and lower intensities by 10 percent; average HbA1c (often written A1C) rose by about 0.08 percentage points on high intensity and 0.06 on lower intensities, and most of the extra diagnoses were in people whose blood sugar was already near the diabetes line before starting 6. The authors judged the heart and stroke benefit to outweigh this; people with prediabetes are the most likely to cross the line.

ALT, a liver enzyme, rose to more than 3 times the upper limit and stayed there in about 0.7 percent of people in trials; serious liver injury is rare 1. Liver enzymes explained covers a mild rise, and fatty liver the most common reason ALT is high before starting. The label also notes rare reports of memory loss or confusion, generally not serious and gone after stopping 1.

Aching muscles on atorvastatin: what prescribers usually check and try

  1. 1Tell the prescriberSay where the aches are, when they started and what else changed, such as new exercise or a new medicine.
  2. 2Check CK and, if suggested, thyroidA creatine kinase (CK) test shows whether muscle is breaking down; what a high CK means explains the cut-offs. A TSH test (the standard thyroid check) may be added, since an underactive thyroid raises muscle risk 1.
  3. 3A planned pause, if the prescriber suggests itThe prescriber may suggest a short break and a restart to see whether the aches follow the tablet. In the SAMSON trial, about 90 percent of the symptoms people felt on a statin also came on placebo 10. Do not stop on your own; with weakness, fever or dark urine, call the same day.
  4. 4Adjust if they returnThe prescriber may then try a lower dose, a different statin, dosing on alternate days (outside the label's once-daily dosing, though some prescribers use it), or adding a non-statin drug.

Our CoQ10 guide calls easing statin muscle aches the supplement's "one use with real, if mixed, evidence". Genetics can matter too: people with a reduced-function SLCO1B1 gene variant clear atorvastatin more slowly, and the CPIC 2022 guideline suggests starting at 40 mg or less (20 mg or less for poor function), or another statin, when that result is known 12.

Drugs and foods that interact with atorvastatin

Drugs that block CYP3A4, the liver enzyme that breaks atorvastatin down, or OATP1B1, the transporter that carries it into liver cells, raise its blood levels and the risk of muscle damage. The US label sets these limits 1.

Drug or foodWhat happensLabel guidance
Clarithromycin, itraconazole, letermovir, elbasvir with grazoprevir, and HIV medicines such as darunavir or saquinavir boosted with ritonavirAtorvastatin levels riseKeep atorvastatin at 20 mg a day or less 1
NelfinavirAtorvastatin levels riseKeep atorvastatin at 40 mg a day or less 1
Cyclosporine, tipranavir with ritonavir, glecaprevir with pibrentasvirLarge rise in atorvastatin levelsAvoid the combination 1
GemfibrozilHigher risk of muscle damageAvoid the combination 1
Fenofibrate, niacin at 1 g a day or more, colchicine, ledipasvir with sofosbuvirMuscle damage reported with the combinationWeigh the combination with the prescriber 1
Grapefruit juiceBlocks CYP3A4 in the gutAvoid large amounts, more than 1.2 liters a day 1
AlcoholNo direct interaction; heavy drinking adds liver strainCaution in people who drink substantial amounts 1

Short courses also raise atorvastatin levels. A five-day clarithromycin prescription for a chest infection is a common way the 20 mg limit gets missed, so mention atorvastatin to the pharmacist every time.

The blood tests that go with atorvastatin

The 2026 guideline recommends a lipid panel within 12 weeks of starting, to check your response and whether the tablets are being taken, then once a year 7; since the full effect takes about 4 weeks, 4 to 12 weeks after starting or a dose change reads it fairly 1. Keep the panel from before starting. Why trends beat single readings shows how to compare them, and fasting before a blood test covers the repeat.

WhenTestsWhat they show
Before startingLipid panel (with ApoB if available), ALT, HbA1c or fasting glucose; CK if there were past muscle problems; TSH if an underactive thyroid is suspectedThe baseline every later result is compared with
4 to 12 weeks after starting or a dose changeLipid panelYour own response, and whether the dose is being taken 7
Once a year after thatLipid panelWhether the response holds 7
Only if symptoms appearALT for possible liver trouble, CK for muscle pain or weaknessThe label suggests a liver test before starting, then only when clinically needed 1
At routine checks if blood sugar was borderlineHbA1c or fasting glucoseThe small rise statins can cause 6

The 2026 guideline judges treatment by LDL goals set by risk: below 100 mg/dL (2.6 mmol/L) at borderline or intermediate risk, below 70 mg/dL (1.8 mmol/L) at high risk, and below 55 mg/dL (1.4 mmol/L) with heart or artery disease at very high risk 7; see what an LDL of 70 means and what an LDL of 100 means. On 40 or 80 mg, a drop of about 50 percent is what the dose usually delivers 2 3.

If LDL barely moved, possible reasons include missed doses, a draw taken too soon or normal person-to-person variation, and the prescriber can work out which applies. In familial hypercholesterolemia, an inherited condition where LDL starts very high, the percentage drop is usually similar but the result can stay well above goal, and prescribers often add ezetimibe. A raised ALT or CK, or an LDL short of the agreed goal, is a result to take to the prescriber before changing anything; with muscle or liver symptoms, call the same day.

Lipoprotein(a), an inherited particle the guideline says to measure at least once in adulthood 7, does not fall on atorvastatin, and statins can nudge it up slightly 15, so a high Lp(a) on treatment is expected; what a high Lp(a) means covers what clinicians do about it.

Most labs calculate LDL, and the older Friedewald formula tends to read low under about 70 mg/dL, where the newer Martin-Hopkins formula is more accurate 14. How to read your lipid panel walks through each line, and the cholesterol converter turns mg/dL into mmol/L.

CalculatorLDL calculatorRecalculates LDL from total cholesterol, HDL and triglycerides with both formulas, which matters once atorvastatin brings LDL low.Work it out Free, no accountRead your blood testHave the lipid panel from before atorvastatin and one from after? Read every line of both, free, and see your own percentage drop.Read my results

Who should not take atorvastatin

The current US label lists two situations where it must not be used (contraindications): sudden liver failure or advanced cirrhosis where the liver is no longer coping (decompensated cirrhosis), and allergy to atorvastatin or anything in the tablet 1. The FDA asked in 2021 for pregnancy to come off that list 13, and the current Lipitor label no longer lists it 1. The label still tells prescribers to stop atorvastatin when pregnancy is recognized unless they judge the ongoing need too high, as in some people with heart disease or inherited very high LDL 1. Tell the prescriber as soon as you know or suspect you are pregnant, ideally before trying to conceive, and make that call together. Breastfeeding on atorvastatin is not recommended 1.

Diet still adds to the drop: foods that lower cholesterol covers the ones with trial evidence, do eggs raise cholesterol answers the most common food question, and the heart health guide puts lipids beside blood pressure and blood sugar.

Free, no accountDrop in your lab report and see every marker explained in plain words, placed on the body, against your lab's range. It's read on your device: nothing is uploaded and nothing is kept.
Citations
  1. Lipitor (atorvastatin calcium) tablets, US prescribing information, revised 12/2022. DailyMed, US National Library of Medicine
  2. Jones PH et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial). American Journal of Cardiology, 2003;92(2):152-160
  3. Grundy SM et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation, 2019;139:e1082-e1143
  4. Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. The Lancet, 2010;376:1670-1681
  5. Cholesterol Treatment Trialists' Collaboration. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials. The Lancet, 2022;400:832-845
  6. Cholesterol Treatment Trialists' Collaboration. Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis. The Lancet Diabetes & Endocrinology, 2024;12:306-319
  7. Blumenthal RS, Morris PB et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia. JACC, 2026;87(19):2624-2757
  8. Cannon CP et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes (PROVE IT-TIMI 22). New England Journal of Medicine, 2004;350:1495-1504
  9. Amarenco P et al. High-dose atorvastatin after stroke or transient ischemic attack (SPARCL). New England Journal of Medicine, 2006;355:549-559
  10. Wood FA et al. N-of-1 trial of a statin, placebo, or no treatment to assess side effects (SAMSON). New England Journal of Medicine, 2020;383:2182-2184
  11. Graham DJ et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA, 2004;292(21):2585-2590
  12. Cooper-DeHoff RM et al. The Clinical Pharmacogenetics Implementation Consortium guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and statin-associated musculoskeletal symptoms. Clinical Pharmacology & Therapeutics, 2022;111(5):1007-1021
  13. US Food and Drug Administration. FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy, July 2021
  14. Martin SS et al. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA, 2013;310(19):2061-2068
  15. Tsimikas S et al. Statin therapy increases lipoprotein(a) levels. European Heart Journal, 2020;41(24):2275-2284

Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.